Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm?

A Simon Pickard1, Zhixiao Wang, Surrey M Walton

  • 1Center for Pharmacoeconomic Research, College of Pharmacy, Room 164, 833 S, Wood St (MC886), University of Illinois at Chicago, 60612, USA. pickard1@uic.edu

Health and Quality of Life Outcomes
|March 8, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

A randomised equivalence study of the EQ-5D-5L Shona versions: evaluation of measurement equivalence between digital and paper formats.

Health and quality of life outcomes·2026
Same author

Qualitative assessment of content validity of the modified EQ-HWB-9 by patients, caregivers, and social care users in the United States.

Health and quality of life outcomes·2026
Same author

Item-Level Convergent and Structural Validity of the EQ-HWB-9 in US Informal Caregivers Compared With ASCOT-Carer, CarerQoL, and EQ-5D-5L.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same author

Cardiovascular Risks of Aromatase Inhibitors versus Tamoxifen in Postmenopausal Breast Cancer: A Multinational Cohort Study.

Clinical epidemiology·2026
Same author

Treatment patterns of symptomatic treatments for Alzheimer's disease and related dementias.

BMC geriatrics·2025
Same author

Valuing Child Health: An EQ-5D-Y-3L Value Set for the United States.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2025
Same journal

Childhood visual impairment and health-related quality of life in Ghana: evidence from a cross-sectional study.

Health and quality of life outcomes·2026
Same journal

A multicenter longitudinal study on development and validation of the quality of life scale QLICD-DM (V2.0) for diabetes mellitus based on classical test theory and generalizability theory.

Health and quality of life outcomes·2026
Same journal

Investigating the impact of chronic graft‑versus‑host disease on patient health‑related quality of life: perspectives from patients and carers.

Health and quality of life outcomes·2026
Same journal

Adverse childhood experiences and well-being in middle-aged men in South Korea: mediating role of andropause symptoms.

Health and quality of life outcomes·2026
Same journal

Patient and carer treatment preferences for oral medication in chronic kidney disease: a discrete choice experiment across eight countries.

Health and quality of life outcomes·2026
See all related articles

Choosing different SF-36/SF-12 algorithms significantly impacts cost utility analysis (CUA) results. Brazier

Area of Science:

  • Health economics
  • Outcomes research
  • Psychometrics

Background:

  • Cost utility analysis (CUA) relies on preference-based algorithms for SF-36/SF-12 data.
  • Algorithm selection can influence decision-making in healthcare.
  • Guidance is needed for choosing appropriate SF-36/SF-12 algorithms.

Purpose of the Study:

  • To demonstrate how algorithm choice affects SF-36/SF-12 based CUA.
  • To compare incremental cost-utility ratios (ICURs) across different algorithms.
  • To provide recommendations for algorithm selection.

Main Methods:

  • Utilized data from adult asthma patients and post-stroke patients.
  • Calculated incremental cost-utility ratios (ICURs) using ten published algorithms.
  • Compared and ranked ICURs (dollars/QALY) across datasets and algorithms.

Related Experiment Videos

Main Results:

  • ICURs varied widely across algorithms, from $27,972/QALY to $63,492/QALY.
  • Fryback and Shmueli algorithms yielded higher ICURs with non-overlapping confidence intervals.
  • Algorithm rankings showed strong correlation (r=0.60) between asthma and stroke cohorts.

Conclusions:

  • SF-36/SF-12 algorithms generate diverse ICURs, impacting reimbursement decisions.
  • Brazier algorithms offer strong methodological basis and higher ICURs.
  • Need for a US general population-based SF-36/SF-12 algorithm with robust foundations.